Navigation Links
Inovio Collaborator ChronTech Reports Interim Phase II Clinical Study Results from ChronVac-C Vaccine for Hepatitis C Infection
Date:4/2/2013

BLUE BELL, Pa., April 2, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced the release of preliminary clinical trial results by its collaborator ChronTech AS of their open label phase II clinical study of ChronVac-C®, ChronTech's vaccine to treat hepatitis C virus (HCV) infection. The study investigated the use of the ChronVac-C DNA vaccine administered with Inovio's MedPulserTM-DDS electroporation device followed by a drug regimen (ribavirin + PEG-interferon-a) in chronic HCV positive subjects. These initial results do not show a statistically significant difference so far between treatment outcomes of the vaccinated and non-vaccinated groups. The vaccinated group did display an excellent safety profile.

In this 29 patient phase II study, 17 patients were treated with two monthly vaccinations of ChronVac-C (500 ug) followed by interferon and ribavirin. In the control arm, 12 patients were treated with interferon and ribavirin alone. ChronTech has now made a first analysis 12 weeks after treatment. HCV viral load reduction or elimination is assessed by measuring HCV RNA levels. At treatment week 12, 71% of the pre-vaccinated group had less than 15 international units of HCV RNA compared to 58% in the non-vaccinated group; 65% were HCV RNA negative compared to 58% in the non-vaccinated group. There were no serious adverse events and the number of patients with moderate adverse events was statistically lower in the pre-vaccinated group than in the non-vaccinated group (p<0.05, Fishers exact test). There was no difference in mild adverse events between the groups.

In 2007, ChronTech initiated its phase I dose escalation (167, 500, 1500 mg) study using its ChronVac-C DNA vaccine targeting genotype 1a and NS3/4A antigens delivered with Inovio's MedPulser device. The treatment regimen of four vaccinations delivered with electroporation demonstrated transient reduction in viral l
'/>"/>

SOURCE Inovio Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals to Present at BioCenturys "Future Leaders in the Biotech Industry" Conference
2. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
3. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
4. Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
5. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
6. Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Inovio Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th
8. Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference
9. Inovios Synthetic Flu Vaccine Doubles Rate of Elderly Subjects Displaying Protective Immune Responses
10. Inovio Expands Synthetic Vaccine Intellectual Property License With University of Pennsylvania
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... experimental drug designed to help regulate the blood,s iron supply ... inflammation, according to results from the first human study ... Blood , the Journal of the American Society ... condition that occurs when red blood cells are in short ... anemia, the body does not get enough oxygen, since there ...
(Date:8/27/2014)... , Aug. 27, 2014 ... research report is available in its ... for Application and Approval of Imported ... Practices (2014 Edition) ... Now, Chinese regulations on medical ...
(Date:8/27/2014)... BOSTON , Aug. 27, 2014  Columbia Laboratories, ... Company"), a provider of pharmaceutical development, clinical trial manufacturing, ... industry, today announced that it will participate at the ... Investment Conference, to be held in New ... conference at 11:15am on September 9, 2014 at the ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10
... endpoint Clinical ( www.endpointclinical.com ), a leader in ... of PULSE 2.0™. endpoint PULSE is a proprietary platform ... systems for clinical trials in a fraction of the ... is the ability for project managers to create and ...
... Prime Therapeutics (Prime), a thought leader in pharmacy benefit ... earning it 2011 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) ... fourth consecutive year that Prime has received this certification. ... benefit managers (PBMs) that have agreed to provide pharmacy ...
Cached Medicine Technology:endpoint Launches PULSE 2.0 Allowing Clinical Research Teams to Save Additional Time and Money By Rapidly Deploying Studies With Custom Reporting 2Prime Therapeutics Receives 2011 TIPPS Certification 2
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Arrow, OK (PRWEB) August 27, 2014 When ... their guests a comfortable bed to sleep without breaking the ... the market for a new foam mattress set for the ... to sleep on, Bedding Mart has it all during their ... stock up on some of the best mattresses for the ...
(Date:8/27/2014)... Charlotte, NC (PRWEB) August 27, 2014 Taking ... extremes, the Steele Creek YMCA will host its ... Race on Saturday, September 13 at YMCA Camp ... in three race divisions: adult, youth and teams. Within ... pushing themselves to their physical limit - for a worthy ...
(Date:8/27/2014)... Canada Goose Parkas from CanadaGooseJackor.nu are great. By ... With unique detailing such as buttons, leather trim and a ... in opulence. Recently, the company has unveiled its new range ... , True enough, the new assortment comes in various popular ... off) on all these brand new items. By launching the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The New ... ) is holding free events about “ Sexuality & ... Liz Treston. These straightforward and entertaining discussions are for ... Bussani Mobility (501 Concord Avenue, Mamaroneck, NY) and October ... Avenue, Bethpage, NY). , The New York Mobility ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2
... Healthcare Each Sell Financially Challenged Facilities to ... ... HealthLeaders-InterStudy, NASHVILLE, Tenn., April 9, 2008 ,HealthLeaders-InterStudy, a ... ownership continue to,influence the Miami-area market as for-profit HCA Inc. ...
... Support Foundation Programs, MCLEAN, Va., April 9, ... announced the inaugural,Infinitive Championship Series. This unique series ... of running and triathlon races for,points and prizes. ... collect,points from series events in order to qualify ...
... possible to mimic the tactics used by parasites to ... , That is the hope of Dr Shane Grey ... John Dalton from the Institute for the Biotechnology of ... pair has been awarded a $400,000 grant through the ...
... could be missed, harming long-term survival, study suggests , , ... analysis of breast cancer patient survival suggests it might ... node biopsies. , A team of New York City ... to be free of cancerous cells in their sentinel ...
... a MED3OOO company,that delivers EHR technology to physician ... the Ohio State Medical Association,(OSMA), in Columbus, OH, ... by OSMA to help physician groups make the ... Standards of Excellence Program is available exclusively to,OSMA ...
... WASHINGTON, April 9, 2008 Global Health ... saving lives by improving,health throughout the world, ... Washington, D.C. and Vermont locations., Organizational ... implement a new software system to manage ...
Cached Medicine News:Health News:Miami Hospital Market Sees Shift in Ownership of Two Area Facilities 2Health News:Management Consultancy Announces Inaugural Infinitive Championship Series 2Health News:Manipulating the immune system like a parasite 2Health News:Breast Cancer Lymph Node Biopsy May Need Closer Look 2Health News:Breast Cancer Lymph Node Biopsy May Need Closer Look 3Health News:Breast Cancer Lymph Node Biopsy May Need Closer Look 4Health News:InteGreat Selected to Participate in OSMA's Standard of Excellence Program for EHRs 2Health News:InteGreat Selected to Participate in OSMA's Standard of Excellence Program for EHRs 3Health News:Global Health Council Selects Aptify's Association Management Software 2Health News:Global Health Council Selects Aptify's Association Management Software 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: